tiprankstipranks
Trending News
More News >
Aziyo Biologics (ELUT)
NASDAQ:ELUT
US Market

Aziyo Biologics (ELUT) Technical Analysis

Compare
66 Followers

Technical Sentiment

Overall Consensus
Strong Sell
4Bullish
3Neutral
15Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Aziyo Biologics’s (ELUT) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Aziyo Biologics is a Sell.
Aziyo Biologics’s (ELUT) 20-Day exponential moving average is 1.86, while Aziyo Biologics’s (ELUT) share price is $1.76, making it a Sell.
Aziyo Biologics’s (ELUT) 50-Day exponential moving average is 2.05, while Aziyo Biologics’s (ELUT) share price is $1.76, making it a Sell.

Aziyo Biologics (ELUT) Pivot Points

Jun 18, 2025, 09:21 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.43
1.57
1.67
1.81
1.91
2.05
2.15
Fibonacci
1.57
1.67
1.72
1.81
1.91
1.96
2.05
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aziyo Biologics (ELUT) Moving Averages

Jun 18, 2025, 09:21 AM
Period
Simple
Exponential
MA5
1.84Sell
1.82Sell
MA10
1.87Sell
1.84Sell
MA20
1.82Sell
1.86Sell
MA50
1.99Sell
2.05Sell
MA100
2.46Sell
2.42Sell
MA200
3.14Sell
2.96Sell
Aziyo Biologics’s (ELUT) 10-Day exponential moving average is 1.84, while Aziyo Biologics’s (ELUT) share price is $1.76, making it a Sell.
Aziyo Biologics’s (ELUT) 100-Day exponential moving average is 2.42, while Aziyo Biologics’s (ELUT) share price is $1.76, making it a Sell.
Aziyo Biologics’s (ELUT) stock price is $1.76 and Aziyo Biologics’s (ELUT) 50-day simple moving average is 1.99, creating a Sell signal.
Aziyo Biologics’s (ELUT) stock price is $1.76 and Aziyo Biologics’s (ELUT) 100-day simple moving average is 2.46, creating a Sell signal.
Aziyo Biologics’s (ELUT) stock price is $1.76 and Aziyo Biologics’s (ELUT) 200-day simple moving average is 3.14, creating a Sell signal.

Aziyo Biologics (ELUT) Technical Indicators

Jun 18, 2025, 09:21 AM
Name
Value
Implied Action
RSI (14)
43.41
Neutral
STOCH (9,6)
10.96
Buy
STOCHRSI (14)
33.13
Neutral
MACD (12,26)
-0.04
Sell
ADX (14)
18.12
Buy
Williams %R
-66.87
Buy
CCI (14)
-35.32
Neutral
ATR (14)
0.16
-
Ultimate Oscillator
29.58
Sell
ROC
2.91
Buy
Aziyo Biologics’s (ELUT) Relative Strength Index (RSI) is 43.41, creating a Neutral signal.
Aziyo Biologics’s (ELUT) Trend Strength Indicator (ADX) is 18.12, creating a Buy signal.
Aziyo Biologics’s (ELUT) Commodity Channel Index (CCI) is -35.32, creating a Neutral signal.
Aziyo Biologics’s (ELUT) Price Rate of Change (ROC) is 2.91, creating a Buy signal.

FAQ

Is ELUT a Buy, Hold, or Sell?
Based on ELUT’s technical indicators, ELUT is a Strong Sell.
    What is ELUT’s RSI (14)?
    ELUT’s RSI (14) is 43.41, which suggests ELUT is a Neutral.
      What is ELUT’s MACD?
      ELUT’s MACD is -0.04, which suggests ELUT is a Sell.
        What is ELUT’s 5-day moving average?
        ELUT’s 5-day moving average is 1.84, which suggests ELUT is a Sell.
          What is ELUT’s 20-day moving average?
          ELUT 20-day moving average is 1.82, which suggests ELUT is a Sell.
            What is ELUT’s 50-day moving average?
            ELUT’s 50-day moving average is 1.99, which suggests ELUT is a Sell.
              What is ELUT’s 200-day moving average?
              ELUT’s 200-day moving average is 3.14, which suggests ELUT is a Sell.
                What is ELUT’s Williams % R (14)?
                ELUT’s Williams % R (14) is -66.87, which suggests ELUT is a Buy.
                  What is ELUT’s CCI (14)?
                  ELUT’s CCI (14) is -35.32, which suggests ELUT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis